Cargando…
Proteoglycan Extracted from Ganoderma lucidum Ameliorated Diabetes-Induced Muscle Atrophy via the AMPK/SIRT1 Pathway In Vivo and In Vitro
[Image: see text] Muscle atrophy often occurs in type 2 diabetes (T2D) and leads to an increase in physical disability and insulin resistance. However, there are very few studies that have investigated potential natural products used for this condition. In this study, we demonstrated that FYGL (Fuda...
Autores principales: | Li, Jiaqi, Zhang, Ying, Yu, Fanzhen, Pan, Yanna, Zhang, Zeng, He, Yanming, Yang, Hongjie, Zhou, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448640/ https://www.ncbi.nlm.nih.gov/pubmed/37636971 http://dx.doi.org/10.1021/acsomega.3c03513 |
Ejemplares similares
-
Effects of a Ganoderma lucidum Proteoglycan
on Type 2 Diabetic Rats and the Recovery of Rat Pancreatic
Islets
por: Yu, Fanzhen, et al.
Publicado: (2023) -
Inhibition on α-Glucosidase Activity and Non-Enzymatic Glycation by an Anti-Oxidative Proteoglycan from Ganoderma lucidum
por: Zhang, Ying, et al.
Publicado: (2022) -
Interaction and Inhibition of a Ganoderma
lucidum Proteoglycan on PTP1B Activity for Anti-diabetes
por: Yu, Fanzhen, et al.
Publicado: (2021) -
Pancreatic cancer cell apoptosis is induced by a proteoglycan extracted from Ganoderma lucidum
por: Wu, Xiao, et al.
Publicado: (2021) -
Balancing adipocyte production and lipid metabolism to treat obesity-induced diabetes with a novel proteoglycan from Ganoderma lucidum
por: Wang, YingXin, et al.
Publicado: (2023)